Skip to main content
رجوع
GILD logo

Gilead Sciences, Inc.

جودة البيانات: 100%
GILD
NASDAQ Healthcare Drug Manufacturers - General
KWD 137.34
▲ KWD 0.13 (0.09%)
القيمة السوقية: 170.50B
نطاق اليوم
KWD 136.44 KWD 139.80
نطاق 52 أسبوعًا
KWD 93.37 KWD 157.29
حجم التداول
7,360,842
متوسط 50 يوم / 200 يوم
KWD 141.92 / KWD 123.02
الإغلاق السابق
KWD 137.21

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E 20.0 0.4
P/B 7.5 2.9
ROE % 40.6 3.7
Net Margin % 28.9 3.9
Rev Growth 5Y % 1.9 10.0
D/E 1.1 0.2

السعر المستهدف للمحللين

Hold
KWD 158.710 +15.6%
Low: KWD 105.000 High: KWD 180.000
مكرر الربحية المستقبلي
15.8
ربحية السهم المستقبلية
KWD 8.679
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
30 B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 12.669
KWD 12.209 – KWD 13.252
38 B 6
FY2029 KWD 11.682
KWD 11.257 – KWD 12.219
36 B 6
FY2028 KWD 10.502
KWD 8.620 – KWD 11.850
34 B 8

Insider Trading Activity

Buy ratio (90d) 0.0%
20 transactions
Date Insider Type Shares Price Value
Mar 16, 2026
Mercier Johanna
Chief Comm & Corp Aff Officer
sell 3,000 KWD 144.230 KWD 432,690
Mar 16, 2026
Dickinson Andrew D
Chief Financial Officer
sell 3,000 KWD 144.230 KWD 432,690
Feb 27, 2026
Berger Dietmar
Chief Medical Officer
grant 8,530
Feb 27, 2026
Cain Wettan Keeley M
EVP Gen Counsel, Legal & Comp
grant 470
Jan 20, 2026
Bluestone Jeffrey
Director
other 10,000 KWD 67.450
Jan 20, 2026
Bluestone Jeffrey
Director
sell 5,000 KWD 123.500 KWD 617,500
Dec 29, 2025
O'Day Daniel Patrick
Chairman & CEO
sell 10,000 KWD 124.827 KWD 1,248,272
Dec 15, 2025
Dickinson Andrew D
Chief Financial Officer
sell 3,000 KWD 122.000 KWD 366,000
Nov 28, 2025
Bluestone Jeffrey
Director
other 10,000 KWD 64.920
Nov 28, 2025
Bluestone Jeffrey
Director
sell 5,000 KWD 125.080 KWD 625,400
Nov 17, 2025
Dickinson Andrew D
Chief Financial Officer
sell 2,500 KWD 125.230 KWD 313,075
Oct 15, 2025
Dickinson Andrew D
Chief Financial Officer
sell 2,500 KWD 118.080 KWD 295,200
Sep 15, 2025
Mercier Johanna
Chief Commercial Officer
sell 3,000 KWD 113.570 KWD 340,710
Sep 10, 2025
Mercier Johanna
Chief Commercial Officer
other 9,507
Jul 15, 2025
Mercier Johanna
Chief Commercial Officer
sell 3,000 KWD 111.030 KWD 333,090
Jun 16, 2025
Dickinson Andrew D
Chief Financial Officer
sell 2,500 KWD 110.170 KWD 275,425
Jun 10, 2025
Telman Deborah H
EVP, Corporate Affairs & GC
other 3,056
Jun 10, 2025
Wilfong Diane E.
Interim Corp Controller & CAO
other 2,180
Jun 10, 2025
Dickinson Andrew D
Chief Financial Officer
other 9,146
May 15, 2025
Dickinson Andrew D
Chief Financial Officer
sell 2,500 KWD 99.820 KWD 249,550

النقاط الرئيسية

Revenue grew 1.90% annually over 5 years — modest growth
Earnings grew 1672.92% over the past year
ROE of 40.57% indicates high profitability
Net margin of 28.90% shows strong profitability
Generating 9.46B in free cash flow
PEG of 0.01 suggests growth is underpriced

النمو

Revenue Growth (5Y)
1.90%
Revenue (1Y)2.40%
Earnings (1Y)1672.92%
FCF Growth (3Y)12.88%

الجودة

Return on Equity
40.57%
ROIC18.77%
Net Margin28.90%
Op. Margin40.14%

الأمان

Debt / Equity
1.09
Current Ratio1.68
Interest Coverage11.54

التقييم

P/E Ratio
20.03
P/B Ratio7.54
EV/EBITDA15.87
Dividend Yield0.03%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 2.40% Revenue Growth (3Y) 4.20%
Earnings Growth (1Y) 1672.92% Earnings Growth (3Y) 22.56%
Revenue Growth (5Y) 1.90% Earnings Growth (5Y) 8.13%
Profitability
Revenue (TTM) 29.44B Net Income (TTM) 8.51B
ROE 40.57% ROA 14.42%
Gross Margin 86.69% Operating Margin 40.14%
Net Margin 28.90% Free Cash Flow (TTM) 9.46B
ROIC 18.77% FCF Growth (3Y) 12.88%
Safety
Debt / Equity 1.09 Current Ratio 1.68
Interest Coverage 11.54 Dividend Yield 0.03%
Valuation
P/E Ratio 20.03 P/B Ratio 7.54
P/S Ratio 5.79 PEG Ratio 0.01
EV/EBITDA 15.87 Dividend Yield 0.03%
Market Cap 170.50B Enterprise Value 187.52B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 29.44B 28.75B 27.12B 27.28B 27.31B
Net Income 8.51B 480.00M 5.67B 4.59B 6.23B
EPS (Diluted) 6.78 0.38 4.50 3.64 4.93
Gross Profit 25.52B 22.50B 20.62B 21.62B 20.70B
Operating Income 11.82B 1.66B 7.61B 7.33B 9.92B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 59.02B 59.00B 62.13B 63.17B 67.95B
Total Liabilities 36.41B 39.75B 39.38B 41.96B 46.89B
Shareholders' Equity 22.62B 19.33B 22.83B 21.24B 21.07B
Total Debt 24.59B 26.71B 24.99B 25.23B 26.70B
Cash & Equivalents 7.56B 9.99B 6.09B 5.41B 5.34B
Current Assets 19.89B 19.17B 16.09B 14.44B 14.77B
Current Liabilities 11.81B 12.00B 11.28B 11.24B 11.61B